Skip to content
Home News Contact
info@invasight.com -1

Category: Uncategorized

Invasight closes CHF 4.5 million oversubscribed seed round

Posted on August 16, 2022August 16, 2022 by admin
Invasight closes CHF 4.5 million oversubscribed seed round
Posted in UncategorizedLeave a Comment on Invasight closes CHF 4.5 million oversubscribed seed round

Cancer is too clever to be stopped by a silver bullet

Posted on August 16, 2022August 16, 2022 by admin
Cancer is too clever to be stopped by a silver bullet

Posted in UncategorizedLeave a Comment on Cancer is too clever to be stopped by a silver bullet

Recent Posts

  • Invasight closes CHF 4.5 million oversubscribed seed round
  • Cancer is too clever to be stopped by a silver bullet

Recent Comments

No comments to show.

Archives

  • August 2022

Categories

  • Uncategorized
CONTACT
info@invasight.com
-1
COMPANY
News Contact Us Cookies Policy Privacy Policy Legal notice
LOCATIONS
Zürich, Switzerland 
Balgrist campus, Lengghalde 5,
CH-8008 Zürich, Switzerland 
Basel-country, Switzerland 
Main campus, BaseLink,
Hegenheimerwattweg 167A, 4123 Allschwil 
Munich, Germany 
Landsbergerstrasse 155 (hause 1),
80687, Munich, Germany
© INVASIGHT 2022